REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 115 filers reported holding REVOLUTION MEDICINES INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,919 | +21.7% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $1,577 | +8.2% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $1,458 | +2.7% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $1,419 | +8.4% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,309 | +23.6% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,059 | +87.8% | 50,000 | +110.1% | 0.00% | +200.0% |
| Q4 2022 | $564 | -99.9% | 23,800 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $459,000 | +3.1% | 23,800 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $445,000 | -26.9% | 23,800 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $609,000 | +8.9% | 23,800 | +10.2% | 0.00% | 0.0% |
| Q4 2021 | $559,000 | -4.3% | 21,600 | +2.9% | 0.00% | -50.0% |
| Q3 2021 | $584,000 | -11.8% | 21,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $662,000 | -27.9% | 21,000 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $918,000 | +9.0% | 21,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $842,000 | – | 21,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,909,317 | $75,590,000 | 52.65% |
| TRV GP III, LLC | 7,024,031 | $278,081,000 | 23.88% |
| Ponoi II Management, LLC | 685,011 | $27,120,000 | 19.76% |
| TRV GP IV, LLC | 1,419,900 | $56,214,000 | 18.03% |
| Ponoi Management, LLC | 685,011 | $27,120,000 | 15.52% |
| Column Group LLC | 3,580,252 | $141,742,000 | 12.86% |
| BVF INC/IL | 2,768,049 | $109,587,000 | 4.31% |
| Boxer Capital, LLC | 3,309,264 | $131,014,000 | 4.21% |
| Cormorant Asset Management, LP | 2,495,066 | $98,780,000 | 2.35% |
| Casdin Capital, LLC | 1,634,535 | $64,711,000 | 1.92% |